RO7009789
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7009789, covering 2018-05-22 to 2018-05-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid Tumors [Phase 1]